INT307759

Context Info Confidence 0.00 First Reported 2010 Last Reported 2010 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 1.39 Pain Relevance 0.30

D7Cwr3P (Mus musculus)

Pain Link Frequency Relevance Heat psoriasis 37 96.12 tolerance 1 92.44 rheumatoid arthritis 8 69.40 Arthritis 11 64.32 Inflammation 13 47.64 cva 1 37.08 Adalimumab 3 21.36 Etanercept 5 14.84 cytokine 2 5.00 aspirin 1 5.00

Disease Link Frequency Relevance Heat Thrombosis Related Under Development 22 100.00 Psoriasis 41 96.12 Idiopathic Thrombocytopenic Purpura 1 90.48 Adhesions 1 87.84 Disease 16 71.16 Rheumatoid Arthritis 8 69.40 Inflammatory Bowel Disease 5 66.16 Arthritis 5 64.32 Seronegative Spondarthritis 6 62.08 Fatigue 1 54.72

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

However in that case the thrombocytosis diminished gradually, upon stopping the efalizumab, and after 9 weeks, returned to normal values.

Negative_regulation (diminished) of case associated with thrombosis related under development

1) Confidence 0.00 Published 2010 Journal BMC Dermatol Section Body Doc Link PMC2860341 Disease Relevance 1.39 Pain Relevance 0.30

General Comments

This test has worked.